Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid

Molecular Neurobiology

Volumn 54, Issue 3, 2017, Pages 2079-2089

  Morgese, Maria Grazia ^a   Tucci, Paolo ^a   Mhillaj, Emanuela ^b   Bove, Maria ^b   Schiavone, Stefania ^a   Trabace, Luigia ^a   Cuomo, Vincenzo ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anxiety; Depression; HPA axis; Monoamines; Polyunsaturated fatty acid; Soluble beta amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CORTICOTROPIN RELEASING FACTOR; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SEROTONIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FEMALE; FORCED SWIM TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; OMEGA 3 DEFICIENCY; OPEN FIELD TEST; PREFRONTAL CORTEX; PROTEIN BLOOD LEVEL; RAT; WEIGHT GAIN; ANIMAL; BRAIN; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; METABOLISM; NUTRITIONAL STATUS; PHYSIOLOGY; WISTAR RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DEPRESSION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; MALE; NUTRITIONAL STATUS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84959330448     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9809-2     Document Type: Article

References (87)

1. Simopoulos AP (2011) Importance of the omega-6/omega-3 balance in health and disease: evolutionary aspects of diet. World Rev Nutr Diet 102:10–21. doi:10.1159/000327785
2. Simopoulos AP (2009) Omega-6/omega-3 essential fatty acids: biological effects. World Rev Nutr Diet 99:1–16. doi:10.1159/000192755
3. Simopoulos AP (2009) Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications. World Rev Nutr Diet 100:1–21. doi:10.1159/000235706
4. Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83(6 Suppl):1467S–1476S
5. Katsuki H, Okuda S (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46(6):607–636
6. Bazan NG (1998) The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog Brain Res 118:281–291
7. Williams JH, Errington ML, Lynch MA, Bliss TV (1989) Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341(6244):739–742. doi:10.1038/341739a0
8. Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K (1994) Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]. Nature 370(6486):216–218. doi:10.1038/370216a0
9. Heinrichs SC (2010) Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54(4):447–456. doi:10.1002/mnfr.200900201
10. Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C et al (2004) Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 44(6):509–538
11. McCann JC, Ames BN (2005) Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82(2):281–295
12. Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, De Smedt-Peyrusse V, Labrousse VF et al (2011) Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci 14(3):345–350. doi:10.1038/nn.2736
13. Sullivan EL, Riper KM, Lockard R, Valleau JC (2015) Maternal high-fat diet programming of the neuroendocrine system and behavior. Horm Behav. doi:10.1016/j.yhbeh.2015.04.008
14. Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S (2015) Nutritional aspects of depression. Cell Physiol Biochem 37(3):1029–1043. doi:10.1159/000430229
15. Lucas M, Kirmayer LJ, Dery S, Dewailly E (2010) Erythrocyte n-3 is inversely correlated with serious psychological distress among the Inuit: data from the Nunavik health survey. J Am Coll Nutr 29(3):211–221
16. Ross BM (2009) Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot Essent Fat Acids 81(5–6):309–312. doi:10.1016/j.plefa.2009.10.004
17. Levant B (2013) N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. CNS Neurol Disord Drug Targets 12(4):450–459
18. Park Y, Moon HJ, Kim SH (2012) N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 23(8):924–928. doi:10.1016/j.jnutbio.2011.04.018
19. Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68(7):1056–1061
20. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 9(5):e96905. doi:10.1371/journal.pone.0096905
21. Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN et al (2015) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol 29(5):459–525. doi:10.1177/0269881115581093
22. Colaianna M, Tucci P, Zotti M, Morgese MG, Schiavone S, Govoni S, Cuomo V, Trabace L (2010) Soluble beta amyloid(1–42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159(8):1704–1715
23. Pomara N, Sidtis JJ (2010) Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets. Br J Pharmacol 161(4):768–770
24. Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM et al (2008) Amyloid-associated depression: a prodromal depression of Alzheimer disease? Arch Gen Psychiatry 65(5):542–550
25. McEwen BS, Eiland L, Hunter RG, Miller MM (2012) Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62(1):3–12. doi:10.1016/j.neuropharm.2011.07.014
26. Harauma A, Moriguchi T (2011) Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids 46(5):409–416. doi:10.1007/s11745-010-3523-z
27. Ikemoto A, Ohishi M, Sato Y, Hata N, Misawa Y, Fujii Y, Okuyama H (2001) Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42(10):1655–1663
28. Fedorova I, Salem N Jr (2006) Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fat Acids 75(4–5):271–289. doi:10.1016/j.plefa.2006.07.006
29. McNamara RK, Vannest JJ, Valentine CJ (2015) Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: mechanisms and implications for psychopathology. World J Psychiatry 5(1):15–34. doi:10.5498/wjp.v5.i1.15
30. Aid S, Vancassel S, Poumes-Ballihaut C, Chalon S, Guesnet P, Lavialle M (2003) Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44(8):1545–1551. doi:10.1194/jlr.M300079-JLR200
31. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ (2007) Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61(2):187–197
32. Choleris E, Thomas AW, Kavaliers M, Prato FS (2001) A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25(3):235–260
33. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327–336
34. Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29(4–5):547–569
35. Madore C, Nadjar A, Delpech JC, Sere A, Aubert A, Portal C, Joffre C, Laye S (2014) Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes. Brain Behav Immun 41:22–31. doi:10.1016/j.bbi.2014.03.021
36. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1–3):3–33
37. Adams PB, Lawson S, Sanigorski A, Sinclair AJ (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31(Suppl):S157–161
38. Green P, Hermesh H, Monselise A, Marom S, Presburger G, Weizman A (2006) Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 16(2):107–113. doi:10.1016/j.euroneuro.2005.07.005
39. Larrieu T, Hilal ML, Fourrier C, De Smedt-Peyrusse V, Sans N, Capuron L, Laye S (2014) Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl Psychiatry 4:e437. doi:10.1038/tp.2014.77
40. Boersma GJ, Lee RS, Cordner ZA, Ewald ER, Purcell RH, Moghadam AA, Tamashiro KL (2014) Prenatal stress decreases Bdnf expression and increases methylation of Bdnf exon IV in rats. Epigenetics 9(3):437–447. doi:10.4161/epi.27558
41. Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998) Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813(1):112–120
42. Schaaf MJ, De Kloet ER, Vreugdenhil E (2000) Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 3(3):201–208
43. Sarrazin N, Di Blasi F, Roullot-Lacarriere V, Rouge-Pont F, Le Roux A, Costet P, Revest JM, Piazza PV (2009) Transcriptional effects of glucocorticoid receptors in the dentate gyrus increase anxiety-related behaviors. PLoS One 4(11):e7704. doi:10.1371/journal.pone.0007704
44. Stetler C, Miller GE (2011) Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 73(2):114–126. doi:10.1097/PSY.0b013e31820ad12b
45. Carlezon WA Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF (2005) Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 57(4):343–350. doi:10.1016/j.biopsych.2004.11.038
46. Caraci F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer’s disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626(1):64–71. doi:10.1016/j.ejphar.2009.10.022
47. Sometani A, Kataoka H, Nitta A, Fukumitsu H, Nomoto H, Furukawa S (2001) Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. J Neurosci Res 66(3):369–376
48. Myint AM, Leonard BE, Steinbusch HW, Kim YK (2005) Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 88(2):167–173. doi:10.1016/j.jad.2005.07.008
49. Tomasdottir V, Vikingsson A, Freysdottir J, Hardardottir I (2013) Dietary fish oil reduces the acute inflammatory response and enhances resolution of antigen-induced peritonitis. J Nutr Biochem 24(10):1758–1765. doi:10.1016/j.jnutbio.2013.03.005
50. Hida M, Fujita H, Ishikura K, Omori S, Hoshiya M, Awazu M (2003) Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells. J Cell Physiol 196(2):293–300. doi:10.1002/jcp.10298
51. Hill MN, McEwen BS (2010) Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuro-Psychopharmacol Biol Psychiatry 34(5):791–797. doi:10.1016/j.pnpbp.2009.11.001
52. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB (2009) Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34(13):2733–2745. doi:10.1038/npp.2009.114
53. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG et al (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102(51):18620–18625. doi:10.1073/pnas.0509591102
54. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G et al (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9(1):76–81. doi:10.1038/nm803
55. McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB (2013) Upregulation of CB(1) receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behav Brain Res 237:333–337. doi:10.1016/j.bbr.2012.09.053
56. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121(1):66–72
57. Patrick RP, Ames BN (2015) Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J 29(6):2207–2222. doi:10.1096/fj.14-268342
58. Calder PC (2001) omega 3 polyunsaturated fatty acids, inflammation and immunity. World Rev Nutr Diet 88:109–116
59. James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71(1 Suppl):343S–348S
60. Calder PC (2013) n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 72(3):326–336. doi:10.1017/S0029665113001031
61. Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBS Lett 585(23):3798–3805. doi:10.1016/j.febslet.2011.08.033
62. Blazevic S, Colic L, Culig L, Hranilovic D (2012) Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behav Brain Res 230(1):175–181. doi:10.1016/j.bbr.2012.02.001
63. Sachs BD, Ni JR, Caron MG (2015) Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress. Proc Natl Acad Sci U S A 112(8):2557–2562. doi:10.1073/pnas.1416866112
64. Haenisch B, Bilkei-Gorzo A, Caron MG, Bonisch H (2009) Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem 111(2):403–416. doi:10.1111/j.1471-4159.2009.06345.x
65. Mathieu G, Denis S, Langelier B, Denis I, Lavialle M, Vancassel S (2010) DHA enhances the noradrenaline release by SH-SY5Y cells. Neurochem Int 56(1):94–100. doi:10.1016/j.neuint.2009.09.006
66. Braun D, Madrigal JL, Feinstein DL (2014) Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications. Curr Neuropharmacol 12(4):342–352. doi:10.2174/1570159X12666140828220938
67. Counts SE, Mufson EJ (2010) Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 113(3):649–660. doi:10.1111/j.1471-4159.2010.06622.x
68. Liu X, Ye K, Weinshenker D (2015) Norepinephrine protects against amyloid-beta toxicity via TrkB. J Alzheimers Dis 44(1):251–260. doi:10.3233/JAD-141062
69. Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J et al (2010) Locus ceruleus controls Alzheimer’s disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A 107(13):6058–6063
70. Hjorth E, Zhu M, Toro VC, Vedin I, Palmblad J, Cederholm T, Freund-Levi Y, Faxen-Irving G et al (2013) Omega-3 fatty acids enhance phagocytosis of Alzheimer’s disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. J Alzheimers Dis 35(4):697–713. doi:10.3233/JAD-130131
71. Sanz JM, Chiozzi P, Idzko M, Falzoni S, Fellin S, Trabace L, Di Virgilio F (2009) Activation of microglia by amyloid β requires P2X7 receptor expression. J Immunol 182(7):4378–4385
72. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O’Brien JT (2005) Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162(1):175–177. doi:10.1176/appi.ajp.162.1.175
73. Osorio RS, Gumb T, Pomara N (2014) Soluble amyloid-beta levels and late-life depression. Curr Pharm Des 20(15):2547–2554
74. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13(7):717–728. doi:10.1038/sj.mp.4002055
75. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63(1):116–122
76. Song C, Li X, Leonard BE, Horrobin DF (2003) Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res 44(10):1984–1991. doi:10.1194/jlr.M300217-JLR200
77. Cho SM, Kim HV, Lee S, Kim HY, Kim W, Kim TS, Kim DJ, Kim Y (2014) Correlations of amyloid-beta concentrations between CSF and plasma in acute Alzheimer mouse model. Sci Rep 4:6777. doi:10.1038/srep06777
78. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N (2012) Nutrient intake and plasma beta-amyloid. Neurology 78(23):1832–1840. doi:10.1212/WNL.0b013e318258f7c2
79. Morgese MG, Tucci P, Colaianna M, Zotti M, Cuomo V, Schiavone S, Trabace L (2014) Modulatory activity of soluble beta amyloid on HPA axis function in rats. Curr Pharm Des 20(15):2539–2546
80. Pomara N, Sidtis J (2007) Possible therapeutic implication of Abeta disturbances in depression. Int J Geriatr Psychiatry 22(9):931–932. doi:10.1002/gps.1763
81. Gudmundsson P, Skoog I, Waern M, Blennow K, Palsson S, Rosengren L, Gustafson D (2007) The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am J Geriatr Psychiatr 15(10):832–838. doi:10.1097/JGP.0b013e3180547091
82. Chen M, Inestrosa NC, Ross GS, Fernandez HL (1995) Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213(1):96–103. doi:10.1006/bbrc.1995.2103
83. Tang K, Hynan LS, Baskin F, Rosenberg RN (2006) Platelet amyloid precursor protein processing: a bio-marker for Alzheimer’s disease. J Neurol Sci 240(1–2):53–58. doi:10.1016/j.jns.2005.09.002
84. Giedraitis V, Sundelof J, Irizarry MC, Garevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L (2007) The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer’s disease. Neurosci Lett 427(3):127–131. doi:10.1016/j.neulet.2007.09.023
85. Liem ET, Sauer PJ, Oldehinkel AJ, Stolk RP (2008) Association between depressive symptoms in childhood and adolescence and overweight in later life: review of the recent literature. Arch Pediatr Adolesc Med 162(10):981–988. doi:10.1001/archpedi.162.10.981
86. Pine DS, Goldstein RB, Wolk S, Weissman MM (2001) The association between childhood depression and adulthood body mass index. Pediatrics 107(5):1049–1056
87. Grant WB (2014) Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis 38(3):611–620. doi:10.3233/JAD-130719